Why the study?
What are the treatment results and prognostic factors for children and adolescents with synovial sarcoma receiving multimodal therapy?
Population
42 children and adolescents with synovial sarcoma treated at a single institution between 1966 and 1999
Design
Cohort
Follow-up
median 7.8 years (range 0.2-22.4 years)
Authors
Loading...
Supports IRS grouping and invasiveness as prognostic factors in pediatric synovial sarcoma; leaves optimal multimodal therapy open.
What are the treatment results and prognostic factors for children and adolescents with synovial sarcoma receiving multimodal therapy?
Complete or gross total resection is vital for survival in pediatric localized synovial sarcoma, with radiotherapy improving local control, while the impact of chemotherapy remains unclear.
Okcu et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: